Craig Boerner

January 29, 2024

Global health efforts in urology still a major focus for Joseph Smith Jr., MD

Joseph Smith Jr., MD, recent decision to step back from clinical practice is allowing him to focus entirely on global surgery efforts departmentally with faculty, fellows and residents to provide opportunities he believes are a key part of infusing humanitarian intent into their training.

By Craig Boerner
January 24, 2024

Long-term follow-up pinpoints side effects of treatments for prostate cancer patients

A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population.

By Craig Boerner
January 17, 2024

Bird flu vaccine more effective with potent adjuvant

The avian (bird) influenza vaccine creates a more robust immune response when paired with a potent ingredient known as an adjuvant, according to Vanderbilt research published in The Journal of Infectious Diseases.

By Craig Boerner
October 24, 2023

VUMC seeks public input on blood-clotting agent study

Researchers at Vanderbilt are considering participation in an international study to examine if a blood-clotting medication given to adults with major bleeding or in need of urgent surgery or an invasive procedure can improve survival.

By Craig Boerner
October 16, 2023

ICU antibiotics may be safe for kidneys

A Vanderbilt study found that two antibiotics thought to cause kidney failure in ICU patients with a severe bacterial infection, especially when combined with another antibiotic, may be safer for the kidneys than previously reported.

By Craig Boerner
October 5, 2023

Kidney disease gene also has a protective mutation

African Americans have long been known to be at increased risk of kidney disease due to a dangerous genetic mutation that creates a hole in the kidney cells, but Vanderbilt researchers have now discovered a protective genetic mutation that covers the hole to eliminate the risk.

By Craig Boerner
August 7, 2023

Effective medications for opioid use disorder rarely used

Vanderbilt research shows that most individuals diagnosed with opioid use disorder are not on recommended medications and even fewer remain in care.
By Craig Boerner
July 17, 2023

World-first clinical trial to help millions with penicillin allergies

Many low-risk patients with a penicillin allergy were able to have their penicillin allergy label removed through a simple procedure known as “direct oral challenge” as part of a world-first multicenter randomized control trial known as the Penicillin Allergy Clinical Decision Rule (PALACE) study.
By Craig Boerner
July 12, 2023

Musical rhythms shown to improve language processing in children with Developmental Language Disorder

Musical rhythms can help children with speech and language processing difficulties in finding their voice by improving their capacity to repeat sentences they just heard, according to a study led by a Western Sydney University researcher and co-authored by Vanderbilt University Medical Center.
By Craig Boerner
July 7, 2023

Rett syndrome drug studied at Vanderbilt approved for patients

The first drug to treat the symptoms of Rett syndrome was recently approved, following a Nature Medicine study publishing results from the pivotal phase 3 LAVENDER study led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety of trofinetide.
By Craig Boerner
June 8, 2023

Study finds Mark Cuban’s Cost Plus Drug Company could save taxpayers millions on Medicare generic oncology drugs

Vanderbilt research finds that the U.S. government could save taxpayers between $228 million-$2.15 billion a year if insurers who operate its Medicare Part D plans purchased seven generic oncology drugs at the same prices obtained by the Mark Cuban Cost Plus Drug Company.
By Craig Boerner
June 5, 2023

Physical security pilot program ongoing

Vanderbilt University Medical Center is piloting several new physical security measures, including metal detectors.
By Craig Boerner